Revolutionary New Test for Cancer

Use the AMAS Test to detect and defeat nearly ANY form of cancer

It’s new and it’s called the AMAS test. Nothing else comes close to this patented test which has already been tested on 8,000 patients. It was developed by a doctor at Boston University.

The test couldn’t be easier. The doctor takes a blood sample and screens it for a substance called Anti-Malignan Antibody in Serum (AMAS).

The antibody is manufactured by your own immune system in response to any common kind of cancer cell. This is a factor in the blood that goes up regardless of the type of cancer or malignancy. The false positives and negativities in this test are less than 1%.

With the AMAS test, you can reliably surmise when cancer is lurking somewhere in your body and take action at once.

Breast cancer, prostate cancer, lung cancer, colon cancer, you name it… your chances for beating any cancer will skyrocket with this early detection.

The AMAS test is normal (negative) in non-cancerous bodies; terminal cases; and in recovered cases. It is positive in early cancer and detects early cancer 18 months ahead of other cancer tests. The AMAS test will monitor progress in response to treatment. This is valuable!

Exciting! You bet. If there’s any cancer in your family, AMAS should absolutely be part of your regular checkup.

Your doctor probably hasn’t heard of the AMAS test. It’s marketed under the name "Target Reagent."

The AMAS Test:

• Detects all types of active, non-terminal cancer, regardless of site or tissue type affected
• Is 95% to 99% accurate
• Detects tumors as small as a pencil dot
• Distinguishes between benign and malignant tumors
• Can reduce the need for traditional testing methods such as PAP smears, mammograms, PSAs and biopsies
• Is paid for by Medicare and other insurance companies, CPT (billing) code 86-317

The AMAS test is one of the best diagnostic aids available today for the early detection and monitoring of cancer. It is superior to conventional blood tests such as the PSA (Prostate Specific Antigen), CEA and CA125, which measure antigen, a cancer indicator that is not detectable until until late in the disease. Thus, these tests are especially poorly suited for early detection and are not suitable as early biomarkers in chemoprevention.

The AMAS test works by indicating the presence of a cancer-specific antibody, anti-malign. A function of the immune system, anti-malign antibody is released at the onset of cancer. More than 3,314 double-blind studies have proven a direct correlation between the presence of anti-maiign antibody and all types of active, none-terminal cancer.

The specificity and 95% to 99% accuracy of the AMAS test permits confirmation of a diagnosis of cancer while reducing or eliminating the need for other traditional detection tests. These include mammograms, biopsies, x-rays, CT scans, MRIs, and other expensive, uncomfortable procedures. It is easy to see that the medical people might want this to be kept secret.

High risk individuals are recommended to begin using the AMAS test as early as age 30.

High risk means:

• Anyone who has been diagnosed or treated for cancer and is concerned about monitoring for recurrencees
• Anyone coming from a family with a history of cancer
• Anyone who smokes or smoked cigarettes
• Research has determined that obesity is a higher risk factor than a history of cancer in the family

The Cost:

The AMAS kit itself is FREE. The current cost of processing an AMAS test is $135.00 USD.

Please note, the costs of drawing the blood, separating the serum and shipping the serum in dry ice by overnight FEDEX morning delivery are not paid by Oncolab.

An AMAS test and shipping kit is needed for the test. It uncludes specially-designed collecting tubes, technician instructions, medical authorization forms and clinical documentation. The kit is also a shipping box, complete with packaging materials needed to ship the blood sample to Oncolab, the only source for an AMAS test.

To obtain your AMAS test and shipping kit from Oncolab, call before 6 pm. Eastern Standard Time on (800) 9CA-TEST or (617) 536-0850.

Alternatively, you can download the AMAS Test Brochure or Requisition Form in PDF format.

Or visit AmasCancerTest.com to learn more about this innovative aid in early cancer diagnosis and follow-up.

After receiving your AMAS test kit:

• Get a doctors signature to approve your blood test.
• Schedule your local blood draw between Monday and Thursday. SmithKline and Lab Corp are familiar with specifications of drawing a blood sample for Oncolab’s AMAS test.
• Ask the lab if it will supply three pounds of dry ice, needed for shipping your blood sample to Oncolab. If not, ice cream parlors are a good source for dry ice. Pick it up on the day of the blood draw.
• Fill out all insurance and authorization forms. Bring them to your blood lab, they are sent to Oncolab with your blood sample.
• If your doctor includes a fax number on the authorization form, you can receive results in three to seven days.

See your doctor for AMAS test results and any follow-up recommendations as detailed in the clinical documentation accompanying your test kit.

AMAS can detect nearly any type of cancer

The AMAS test can be used to detect all types of cancer. A positive reading indicates that there are cancerous cells in your body, but it cannot specify the type or the location. But as with the infrared imaging procedure I wrote about yesterday, it offers a good alternative for routine screening. With such high accuracy rates, a negative AMAS reading means that a mammogram or other screening procedure is not necessary. And a positive reading would be followed by additional tests anyway - so its lack of specificity doesn’t pose any real obstacles.

All known cancer cells contain malignan. The body zeros in on this with an antibody called anti-malignan. This blood test measures the amount of anti-malignan activity going on in the body. It is 95% accurate according to journal reports of double-blind, multi-center testing. Studies show accuracy rises to an amazing 99% with repeat testing. This makes it much more accurate than many biopsies. It is often accompanied with a CBC (complete blood count) to measure general immune status, since it would not be valid to use this test with a non-functioning immune system. It is FDA approved, and the lab accepts Medicare as full payment.

Talk to your doctor

AMA was first discovered in the mid-1980s, and the AMAS test has been available for over a decade - but still, most doctors are unaware of it.

If you are interested in taking the AMAS test, talk to you doctor. Ask him to check out the information on AmasCancerTest.com, and to call 1-800-922-8378 to request a packet of scientific peer-reviewed literature demonstrating AMAS’ benefits.

The AMAS test kit is FREE … and includes journal studies, an insulated box and a request form to be signed by a doctor.

For best results, use a lab with a refrigerated centrifuge to draw the blood. The blood must be shipped in dry ice, and marked "overnight for morning delivery" at patient’s expense.

Is the AMAS test available in other countries?

Yes. Serum specimens are sent in dry ice from all over the world to the one lab (Oncolab, Inc.) in Boston, USA. So, no matter where you are in the world, you can order your free kit and follow the instructions contained therein.

For patients outside the USA, this test may be claimable through your private health insurance, but since this can change from country to country, and depend on your health care provider, we would recommend you do your own research. And make sure you have the support of your treating physician. Patient costs may also vary.

Some follow up data …

Malignin is a peptide found in people with a wide range of cancers. If the anti-malignan antibody in detected in the blood, it means that the body detected the presence of this peptide, and launched an immune response against it.

Clinical studies have shown that the AMAS test is up to 95 percent accurate on the first reading, and up to 99 percent accurate after two readings.

In one study at Beth Israel Hospital in New York, the AMAS test demonstrated amazing accuracy. Within the study group of 125 people, the test was positive for 21 people who were later confirmed to have cancer, while it was negative for 97 people who showed no signs of cancer. The remaining seven people produced positive readings on the AMAS test but showed no signs of cancer; yet the study notes that all were symptomatic, had a family history of cancer, or both - indicating that the AMAS test may have detected a problem that conventional screening methods could not find.

There have been more than 4,000 doubleblind studies of AMAS Test accuracy in the past ten years. The 99 percent sensitivity of the test has convinced Great Britain’s National Health Service to start buying it as part of the current national effort to eliminate breast cancer early.

Oncolgy Times reports that "The National Health Service sent an invitation to every woman in the UK between the ages of 50 and 64 urging them to get a free mammogram. Should all six million accept, as many as 500,000 would be expected to have abnormal mammograms. Only 50,000 of this group of women would be expected to have cancer. Rather than do 500,000 biopsies, the Health Service is buying a preliminary number of AMAS tests (as a backup tool) for cancer screening as abnormal mammograms appear.

Follow the links below for discussion papers (pros & cons) on the AMAS Test and why your GP may not have heard of it.

http://www.amascancertest.com
http://www.obgyn.net/industry/articles/000525-AMAS.htm
http://www.pathguy.com/malignin.htm
http://www.bcaction.org/Pages/SearchablePages/1996Newsletters
http://www.annieappleseedproject.org/conwdrsambog.html
http://www.annieappleseedproject.org/amastest.html